Series-Pharma-Healthcare-Engineering on Sakura Sky: Cloud, Data, Security

Patient Data Across Boundaries

Tue, 06 Oct 2026 00:00:00 -0400

A trial that enrols patients in the EU, the US, Singapore, and Brazil holds its data under four data protection regimes. They don’t all apply to every record. Which rules govern a participant’s data depends on where that participant enrolled, what they agreed to, and who holds the copy in question. The trial’s documents capture most of this: the protocol, the consent forms, the data transfer agreements. The data itself usually carries the site, the country, and the consent date, but rarely the legal basis, the permitted purposes, or the optional consents a participant did or didn’t give.

Your Lab Notebook Is a Data Product

Mon, 05 Oct 2026 00:00:00 -0400

When your corporate development team has a term sheet for out-licensing a preclinical programme, the partner’s diligence list is likely to run to several hundred lines. While most will be routine, a handful will land on the research organisation, and they tend to look like these four, paraphrased from the kind that appear in life sciences licensing and M&A diligence:

Chain of Custody for Trial Data

Fri, 02 Oct 2026 00:00:00 -0400

Between two transfers from the central laboratory, one LDL cholesterol result in a cardiovascular trial fell from 3.1 to 2.4 mmol/L. The value was participant 1047’s reading at visit 6, an input to the trial’s primary endpoint, the percent change in LDL-C from baseline. Below is everything the sponsor’s clinical data repository recorded about the change.